QOL MEDICAL, LLC DISCONTINUES SPONSORSHIP OF THE ¹³C-SUCROSE BREATH TEST PROGRAM EFFECTIVE MARCH 1, 2025
VERO BEACH, Fla., Feb. 19, 2025 /PRNewswire/ -- QOL Medical, LLC, a ground-breaking rare disease pharmaceutical company, has announced that it will no longer sponsor the 13C-sucrose breath test program,